United Therapeutics Corporation
TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS

Last updated:

Abstract:

Provided are treprostinil derivatives with a reduced ability to form undesired impurities in a pharmaceutical formulation, such as a dry powder formulation, further containing a carboxyl group containing inactive ingredient, such as fumaryl diketopiperazine.

Status:
Application
Type:

Utility

Filling date:

2 Mar 2022

Issue date:

8 Sep 2022